Abstract
Adhesion molecules are intimately involved in mediation of proper cell—cell contacts and communications in a wide variety of biological functions. During malignant trasformation, cells often lose precisely regulated contacts to the mircoenvironment. This may result in an increase of the amount of soluble adhesion molecules in blood circulation. In this review, we will present data on soluble forms of one adhesion molecule, CD44, and discuss the possibilities of using CD44 analyses in clinical practice.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303–1313
Banks RE, Glaring AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 68: 122–124
Bazil V (1995) Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 16: 135–140
Bazil V, Horejsi V (1992) Shedding of the CD44 adhesion molecule from leuckocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J Immunol 149: 747–753
Bazil V, Strominger JL (1994) Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. J Immunol 152: 1314–1322
Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A (1995) CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128: 687–698
Brown TA, Bouchard T, StJohn T, Wayner E, Carter WG (1991) Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113: 207–221
Camp RL, Scheynius A, Johansson C, Pure E (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178: 497–507
Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muinos FX, Fresno M, Sanchez-Madrid F (1991) Down-regulation by tumor necrosis factor-a of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol 21: 3045–3048
Carter WG, Wayner EA (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263: 4193–4201
Christiansen I, Gidlof C, Wallgren AC, Simonsson B, Totterman TH (1994) Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood 84: 3010–3016
D’Agostino L, Pignata S, Daniele B, Ventriglia R, Ferrari G, Ferraro C, Spaguolo S, Lucchelli P, Mazzacca G (1989) Release of diamine oxidase into plasma by glycosaminoglycans in rat. Biochim Biophys Acta 993: 228–234
Dalchau R, Kirkley J, Fabre JW (1980) Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol 10: 745–749
Gearing AJH, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14: 506–512
Goldstein LA, Zhou DF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC (1989) A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56: 1063–1072
Guo Y-J, Liu G, Wang X, Jin D, Wu M, Jing M, Sy M-S (1994) Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in proteins with gastric or colon cancer. Cancer Res 54: 422–426
Gunthert U, Hoffmann M, Ruby W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13–24
Harning R, Mainolfi E, Bystryn J-C, Henn M, Merluzzi VJ, Rothlein R (1991) Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. 51: 5003–5005
Haynes BF, Harden EA, Telen MJ, Hemler MR, Strominger JL, Palker TJ, Scearce RM, Eisenbarth GS (1983) Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. J Immunol 131: 1195–1200
Haynes BF, Telen MJ, Hale LP, Denning SM (1989) CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10: 423–428
Heider KH, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals S (1993) A human homologue of the rat metastasis-associated variant CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227–233
Jackson DG, Schenker T, Waibel R, Bell Jl, Stahel RA (1994) Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer 8: 110–115
Jackson DG, Bell Jl, Dickinson R, Timans J, Shields J, Whittle N (1995) Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128: 673–685
Jacobson K, O’Dell D, Holifield B, Murphy TM, August JT (1984) Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol 99: 1624–1633
Jalkanen S, Bargatze R, Herron LR, Butcher EC (1986) A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16: 1195–1202
Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 141: 1615–1623
Jalkanen S, Joensuu H, Soderstrom K-O, Klemi P (1991) Lymphocyte homing and clinical behavior of non-Hodgkin’s lymphoma. J Clin Invest 87: 1835–1840
Katoh S, McCarthy JB, Kincade PW (1994) Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol 153: 3440–3449
Kaufmann M, Heider K-H, Sinn H-P, von Minckwitz G, Ponta H, Herrlich P (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615–619
Koopman G, van Kooyk Y, de Graaff M, Meijer CJLM, Figdor CG, Pals ST (1990) Triggering of the CD44 antigen on T-lymphocytes promotes T-cell adhesion through the LFA-1 pathway. J Immunol 145: 3589–3593
Letarte M, Iturbe S, Quackenbush EJ (1985) A glycoprotein of molecular weight 85,000 on human cells of B-lineage: Detection with a family of monoclonal antibodies. Mol Immunol 22: 113–119
Li H, Hamou MF, de Tribolet R, Jaufeerally M, Diserens AC, Van Meir EG (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53: 5345–5349
Lucas MG, Green AM, Telen MJ (1989) Characterization of the serum ln(Lu)-related antigen: identification of a serum protein related to erythrocyte p80. Blood 73: 596–600
Mali M, Andtfolk H, Miettinen HM, Jalkanen M (1994) Suppression of tumor cell growth by Syndecan-1 ectodomain. J Biol Chem 269: 27795–27798
Miyake K, Underhill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69–75
Omary MB, Trowbridge IS, Letarte M, Kagnoff MF, Isacke CM (1988) Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 27: 460–464
Pals ST, Hogervorst F, Keizer GD, Thepen T, Horst E, Figdor CG (1989a) Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol 143: 851–857
Pals ST, Horst E, Ossekoppele G, Figdor CG, Scheper RJ, Meijer CJLM (1989b) Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin’s lymphoma. Blood 73: 885–888
Picker LJ, de los Toyos J, Telen MJ, Haynes BF, Butcher EC (1989) Monoclonal antibodies against the CD44 (In(Lu)-related p80), and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol 142: 2046–2051
Rapraeger A, Krufka A, Olwin B (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705–1708
Ristamäki R, Joensuu H, Salmi M, Jalkanen S (1994) Serum in malignant lymphoma: an association with treatment response. Blood 84: 238–243
Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 431–442
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerthe U, Bell Jl (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. PNAS 89: 12160–12164
Spertini O, Callegari P, Cordey AS, Hauert J, Joggi J, von Fiedner V, Schapira M (1994) High levels of the shed form of L-selectin are present in patients with leukemia and inhibit blast cell adhesion. Blood 84: 1249–1256
Stamenkovic I, Amiot M, Pesando JM, Seed B (1989) A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057–1062
Sy MS, Guo YJ, Stamenkovic (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859–866
Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1ß. Nature 361: 79–82
Telen MJ, Eisenbarth GS, Haynes BF (1983) Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran IN(Lu) gene. J Clin Invest 71: 1878–1886
Tsujisaki M, Imai K, Hirata H, Hanzawa Y, Masuya J, Nakano T, Sugiyama T, Matsui M, Hinoda Y, Yachi A (1991) Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 85: 3–8
Webb DSA, Shimizu Y, van Seventer GA, Shaw S, Gerrard TL (1990) LFA-3, CD44, and CD45: Physiologic triggers of human monocyte TNF and IL-1 release. Science 249: 1295–1297
Wielenga VJ, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754–4756
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ristamäki, R., Joensuu, H., Jalkanen, S. (1996). Does Soluble CD44 Reflect the Clinical Behavior of Human Cancer?. In: Günthert, U., Schlag, P.M., Birchmeier, W. (eds) Attempts to Understand Metastasis Formation III. Current Topics in Microbiology and Immunology, vol 213/3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80071-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-80071-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80073-3
Online ISBN: 978-3-642-80071-9
eBook Packages: Springer Book Archive